Skip to content

How does reducing sitting time improve glucose and lipid metabolism? A study to identify underlying mechanisms

How does reducing sitting time improve glucose and lipid metabolism? A study to identify underlying mechanisms - SITLESS 4

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46730
Enrollment
33
Registered
2017-09-27
Start date
2017-12-12
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin resistance obesity overweight

Interventions

Participants will perform three regimes of each four days: 1) sitting regime (sitting 14h/day), 2) exercise regime (sitting 13h/day with cycling 1h/day) and 3) sit less regime (sitting 9h/day, stand

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Caucasian postmenopausal females. Aged 45-70 years at start of the study. Body mass index (BMI) 25 * 35 kg/m2. Stable dietary habits (no weight loss or gain >5kg in the past 3 months) Sedentary lifestyle (not more than 2.5 hours of intensive exercise per week in the past 3 months)

Exclusion criteria

Exclusion criteria: Type 2 diabetes Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other). Alcohol consumption of >2 servings per day. Smoking in the past 6 months. Failed sitless try-out day. Mental or physical disability which interferes with physical activity. Reported participation in night shift work 2 weeks prior to the start of the study and during study participation.

Design outcomes

Primary

MeasureTime frame
* Insulin sensitivity by implementing a 2-step hyperinsulinemic euglycemic clamp

Secondary

MeasureTime frame
* Ex vivo skeletal muscle mitochondrial respiration * Plasma substrate metabolism markers * Plasma cardiometabolic markers * Energy expenditure * Average resting blood pressure over 30 min * Intrahepatic lipid content

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)